Understanding protection from SARS-CoV-2 by studying reinfection
- 22 October 2020
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 26 (11) , 1680-1681
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI138709)
This publication has 12 references indexed in Scilit:
- Humoral Immune Response to SARS-CoV-2 in IcelandNew England Journal of Medicine, 2020
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19New England Journal of Medicine, 2020
- Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome SequencingClinical Infectious Diseases, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan WomenEBioMedicine, 2017
- Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity in HIV-Infected Infants Is Associated with Reduced MortalityCell Host & Microbe, 2015
- HIV-1 Superinfection Occurs Less Frequently Than Initial Infection in a Cohort of High-Risk Kenyan WomenPLOS Pathogens, 2013
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- A Patient with HIV-1 SuperinfectionNew England Journal of Medicine, 2002
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990